The lab is part of a funded joint effort headed by Dr. John Wikswo and Vanderbilt Institute for Integrative Biosystems Research and Education (VIIBRE) to model tuberous sclerosis complex with patient-derived iPSCs. We have also been awarded an internal grant from the Engineering Immunity TIPs program to develop biologicals that direct interleukin signaling. We are excited to embark in these new directions!